Directions – Take 1 tablet daily
"*" indicates required fields
Dutasteride, the active ingredient in Avodart, inhibits both type I and type II 5-alpha-reductase enzymes responsible for converting testosterone into DHT. By reducing DHT levels, dutasteride may help prevent hair follicle shrinkage, potentially slowing hair loss and promoting regrowth.
Research indicates that dutasteride can be more effective than finasteride (Propecia) in increasing hair count and thickness in men with male pattern baldness. However, it's important to note that Avodart is not licensed for hair loss treatment in the UK, and its use for this purpose should only be considered under the guidance of a healthcare professional.
Users may observe a reduction in hair loss after three to six months of consistent daily use. Significant hair regrowth might take up to a year or more. Continuous use is essential to maintain any benefits, as stopping the medication can lead to the return of hair loss.
Results after 6 months:
Many users report a noticeable decrease in hair loss, with some observing initial signs of regrowth.
Results after 1 year:
Significant improvements in hair density and thickness are often reported, along with continued prevention of further hair loss.
Results after 5 years:
Long-term use may lead to sustained hair density and, in some cases, continued gradual regrowth.
Dutasteride inhibits both type I and type II 5-alpha-reductase enzymes, leading to a significant reduction in DHT levels. This decrease helps prevent the miniaturization of hair follicles, thereby reducing hair loss and potentially promoting regrowth.
Common Side Effects:
Uncommon Side Effects:
Most side effects are reversible upon discontinuation of the medication. If any side effects persist or become bothersome, consult a healthcare professional.
REPORTING AVODART SIDE EFFECTS
If you experience any adverse effects, report them to your doctor or pharmacist. In the UK, side effects can also be reported through the Yellow Card Scheme, which helps monitor the safety of medications.
Pregnancy and Women: Avodart is contraindicated in women who are or may become pregnant. Handling leaking capsules can pose risks to a male fetus.
Blood Donation: Men taking Avodart should not donate blood until at least six months after their last dose to prevent the risk of administering the drug to pregnant women via transfusion.
Pediatric Use: Avodart is not indicated for use in children.
Storage: Store in a cool, dry place away from direct sunlight and out of reach of children.
Allergic Reactions: Discontinue use and seek immediate medical attention if signs of an allergic reaction occur, such as rash, itching, swelling, or difficulty breathing.